Faecal transplants can treat some cancers — but probably won’t ever be widely used
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement Liam Drew is a freelance science journalist in Kent, UK. You can also search for this author in PubMed Google Scholar Samples that will be used in faecal microbiota transplants, which can enhance responses to cancer immunotherapy, sit in a freezer.Credit: M. Scott Brauer/Redux/eyevine In February 2021, a pair of remarkable clinical trials was published1,2. Each one involved people with melanoma. Some participants had been successfully treated using drugs called immune checkpoint inhibitors, which help the body to destroy cancer cells. The others had failed to respond to th
OUTLOOK 04 July 2024 Gut microbiota could be crucial to the success or failure of immunotherapy. Donated stool might give oncologists a way to tip the balance, but the real excitement lies in what comes next. By Liam Drew0 Liam Drew Liam Drew is a freelance science journalist in Kent, UK. In February 2021, a pair of remarkable clinical trials was published1,2. Each one involved people with melanoma. Some participants had been successfully treated using drugs called immune checkpoint inhibitors, which help the body to destroy cancer cells. The others had failed to respond to the…
saved by
related reading
- Australia gives world-first approval for faecal transplants to restore gut health | Health | The Guardiantheguardian.com
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Immunotherapy for Cancer - NCIcancer.gov
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Enteromeenterome.com
- Notionnotion.so
- Medicine's Endgamenotboring.co
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- News & Events | JAISTjaist.ac.jp
- Notionnotion.so
- UpToDateuptodate.com
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanomanature.com